Participants 44 107 3
in patients with acute ischaemic stroke and atrial fibrillation
Participants 212 272 3
Patients with acute ischaemic stroke and atrial fibrillation
Participants 510 789 9
multicentre, randomised, double-blind, and double-dummy trial on the effect of low-molecular-weight heparin (LMWH, dalteparin 100 IU/kg subcutaneously twice a day) or aspirin (160 mg every day) for the treatment of 449 patients with acute ischaemic stroke and atrial fibrillation
